For richer charts and full features, open SpikePanel on desktop.
Graded daily on value C, growth B, profitability B, momentum B-, revisions B+. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $MDLZ are available with SpikePanel Pro.
Key events, in time order
CEO comments and growth data echo post-earnings focus; no new financial facts
Q2 sales and earnings beat; higher organic growth view, but margin pressure in focus
Three limited-edition flavors launch Aug 24; fan vote determines official 2027 return, boosting engagement
Amundi increased its MDLZ holdings in Q1, indicating institutional confidence.
BofA reduced its MDLZ holdings in the latest quarter, reflecting institutional repositioning.
Q2 earnings and sales beat, FY organic sales outlook raised; dividend hike of only 4%, smallest since spin-off.
Q2 revenue and adj EPS beat; FY organic net revenue growth raised to at least 2%
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice